Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aytu Biopharma Inc (NQ: AYTU )

0.2155 -0.0095 (-4.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 839,738
Open 0.2081
Bid (Size) 0.2260 (20)
Ask (Size) 0.2290 (3)
Prev. Close 0.2250
Today's Range 0.2081 - 0.2289
52wk Range 0.1482 - 2.400
Shares Outstanding 62,432,727
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT(R) Prescriptions Generated Since Inception of RxConnect
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga

Performance

YTD
-86.10%
-86.10%
1 Month
+36.48%
+36.48%
3 Month
-3.36%
-3.36%
6 Month
-57.75%
-57.75%
1 Year
-88.72%
-88.72%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Aytu BioPharma Receives a 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
Via ACCESSWIRE
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Second Year in a Row
Via ACCESSWIRE
Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023
Via ACCESSWIRE
Aytu BioPharma Announces Agreement with Avenue Venture Debt Fund to Extend Interest-Only Period of Company's Term Loan
Via ACCESSWIRE
Aytu BioPharma Announces Strategic Shift, Indefinite Suspension of Clinical Development Programs
Via Benzinga
Aytu BioPharma Announces the Passing of Co-Founder and Board Member Michael Macaluso
Via ACCESSWIRE
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
Via Benzinga
Aytu BioPharma to Report First Quarter Fiscal 2023 Financial Results on November 14, 2022
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Aytu BioPharma Announces Continuing Availability of ADHD Medication Adzenys XR-ODT(R) in Response to Reported Generic Adderall(R) XR Supply Disruptions
Via ACCESSWIRE
Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue
Via ACCESSWIRE
Aytu BioPharma Announces Strategic Shift to Focus on Commercial Operations and Indefinite Suspension of Clinical Development Programs
Via ACCESSWIRE
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Aytu BioPharma's Return On Capital Employed Insights
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For September 27, 2022
Via Benzinga
Aytu BioPharma Announces Addition of Fourth Patent License for AR101/Enzastaurin
Via ACCESSWIRE
Aytu BioPharma's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.